Ariad Pharmaceuticals (ARIA) Stock Skyrockets: What’s Next?

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals is having an incredibly strong day in the market today – and for good reason. The company reported its earnings for the most recent quarter, blowing away expectations. Today, we’ll talk about what we saw from the earnings report, how investors reacted to the news, and what we can … Read more

Today In The Market | EnteroMedics (ETRM), Ariad Pharmaceuticals (ARIA), Baxalta (BXLT), Twitter (TWTR), Facebook (FB)

EnteroMedics Study Data Excites Investors EnteroMedics Inc (NASDAQ: ETRM) EnteroMedics is having a great day in the market today as investors are focused on the an analyses of the company’s ReCharge Study. The analyses demonstrated Excess Weight Loss of 34% and improvement in obesity-related risk factors associated with vBloc. While the data hit the media … Read more

Ariad Pharmaceuticals (ARIA) Stock: Are Investors Losing Acquisition Hopes?

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals is having a horrible day in the market today. This comes after a massive climb last week in which the stock gained more than 40% in a single day. The climb ARIA experienced last week was a result of an announcement of talks between the company and Baxalta … Read more

Stock Market News Today: Ariad Pharmaceuticals (ARIA), Baxalta (BXLT), Twitter (TWTR), Gilead Sciences (GILD), SunEdison (SUNE)

Ariad Pharmaceuticals Declines Baxalta Offer Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) | Baxalta Inc (NYSE: BXLT) One of the biggest conversations in the biotech space has been a discussion with regard to whether or not Baxalta will acquire Ariad Pharmaceuticals. The original offer on the table was $2 billion. However, Ariad Pharmaceuticals declined the offer – … Read more

Baxalta (BXLT) Acquisition Of Ariad (ARIA): The Deal Needs To Be Sweeter!

Baxalta Inc (NYSE: BXLT) | Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) One of the biggest pieces of news in biotech at the moment is Baxalta’s desire to acquire Ariad Pharmaceuticals. However a wrench may have been thrown into the idea. Yesterday, I reported that while we knew the acquisition talks were under way, we didn’t know … Read more

In The Market Today: Ariad Pharmacueticals (ARIA) | Baxalta (BXLT) | MannKind (MNKD) | The Medicines Company (MDCO) | Twitter (TWTR)

Ariad Pharmaceuticals: Is An Acquisition Coming? Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) | Baxalta Inc (NYSE: BXLT) On Friday, Bloomberg broke a story stating that Ariad Pharmaceuticals and Baxalta were in the midst of acquisition talks. The idea here is that Baxalta wants to purchase Ariad Pharmaceuticals to get hold of the work they’ve been doing … Read more

Today In Healthcare: Gilead Sciences (GILD), MannKind Corporation (MNKD), Ariad Pharmaceuticals (ARIA), Nymox Pharmaceutical (NYMX)

Gilead Sciences Climbs On Positive Earnings Gilead Sciences, Inc. (NASDAQ: GILD) Gilead Sciences seems to be today’s biggest story in the healthcare space. While several investors were concerned about the company’s ability to continue to produce earnings growth, those concerns were put to rest last night when the company’s earnings report for the quarter was … Read more

Ariad Pharmaceuticals (ARIA) Stock Declines Slightly After Earnings

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals is down slightly today following the release of their first quarter earnings report. So, we’ll look into the report to figure out why the stock is falling, talk about what the company does, and discuss what we can expect to see from the stock moving forward. ARIA Misses … Read more

Ariad Pharmaceuticals (ARIA) Stock Climbs | CEO To Retire

Ariad Pharmaceuticals, Inc. (NASDAQ: ARIA) Ariad Pharmaceuticals stock is up today on high volume. However, it’s not unfounded growth as there’s a reason for all the madness. Today, ARIA’s CEO announced that he would retire as part of a settlement. So, we’ll talk about who pushed the CEO out of the chair, who will be … Read more